Abstract
In order to understand the molecular mechanism of Tongguan capsule (TGC), a Traditional Chinese Medicine (TCM) for coronary heart disease (CHD), computational approaches of pharmacodynamic modeling were introduced to predict the interaction between drugs and targets about cardiovascular system. Firstly, we employed a molecular docking protocol to study the interaction of natural compounds from TGC and 13 receptors related with CHD, and screened out the potential effective components. Then the distribution of the effective components on ligand-target space was traced out, and two drug-target networks were developed to decipher the multiple components and multiple targets mechanism of TGC. Most importantly, the forecasting results of computational approaches were agreeable with some pharmacological and clinical experiments. The results showed that computational pharmacology can be an efficacious approach for the modern research of TCM in the future.
Keywords: Drug-target Network, Ligand-target Space, Pharmacodynamic(PD) Modeling, Traditional Chinese Medicine, Tongguan capsule (TGC), coronary heart disease (CHD), Traditional Chinese Medicine (TCM), Molecular Mechanism, Computational Pharmacology Methods Salvia, Gaussin distribution, Lipinski's “rule of five”, Astragalus
Letters in Drug Design & Discovery
Title: A New Practice: Study on the Molecular Mechanism of Traditional Chinese Medicine by Computational Pharmacology Methods: Part 2: Pharmacodynamic Modeling and Distribution on Ligand-Target Space of Effective Components
Volume: 8 Issue: 10
Author(s): Ding-Hong Wu, Xiao-Jie Xu, Min-Zhou Zhang and Lei Wang
Affiliation:
Keywords: Drug-target Network, Ligand-target Space, Pharmacodynamic(PD) Modeling, Traditional Chinese Medicine, Tongguan capsule (TGC), coronary heart disease (CHD), Traditional Chinese Medicine (TCM), Molecular Mechanism, Computational Pharmacology Methods Salvia, Gaussin distribution, Lipinski's “rule of five”, Astragalus
Abstract: In order to understand the molecular mechanism of Tongguan capsule (TGC), a Traditional Chinese Medicine (TCM) for coronary heart disease (CHD), computational approaches of pharmacodynamic modeling were introduced to predict the interaction between drugs and targets about cardiovascular system. Firstly, we employed a molecular docking protocol to study the interaction of natural compounds from TGC and 13 receptors related with CHD, and screened out the potential effective components. Then the distribution of the effective components on ligand-target space was traced out, and two drug-target networks were developed to decipher the multiple components and multiple targets mechanism of TGC. Most importantly, the forecasting results of computational approaches were agreeable with some pharmacological and clinical experiments. The results showed that computational pharmacology can be an efficacious approach for the modern research of TCM in the future.
Export Options
About this article
Cite this article as:
Wu Ding-Hong, Xu Xiao-Jie, Zhang Min-Zhou and Wang Lei, A New Practice: Study on the Molecular Mechanism of Traditional Chinese Medicine by Computational Pharmacology Methods: Part 2: Pharmacodynamic Modeling and Distribution on Ligand-Target Space of Effective Components, Letters in Drug Design & Discovery 2011; 8 (10) . https://dx.doi.org/10.2174/157018011797655331
DOI https://dx.doi.org/10.2174/157018011797655331 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Orekhov`s Method: Reassessment of In vitro Lipid Uptake Assays
Recent Advances in Cardiovascular Drug Discovery (Discontinued) Therapeutic Angiogenesis in Ischemic Tissues by Growth Factors and Bone Marrow Mononuclear Cells Administration: Biological Foundation and Clinical Prospects
Current Stem Cell Research & Therapy A Review of the Cardiovascular and Anti-Atherogenic Effects of Ghrelin
Current Pharmaceutical Design Nanotechnology and Antioxidant Therapy: An Emerging Approach for Neurodegenerative Diseases
Current Medicinal Chemistry Adipose Tissue as a Target of HIV-1 Antiretroviral Drugs. Potential Consequences on Metabolic Regulations
Current Pharmaceutical Design Pentraxins: CRP and PTX3 and Cardiovascular Disease
Inflammation & Allergy - Drug Targets (Discontinued) Immunomodulatory Properties of Farnesoids: The New Steroids?
Current Medicinal Chemistry Antioxidants as Potentially Safe Antidotes for Organophosphorus Poisoning
Current Enzyme Inhibition Novel C-9, 9'-O-acyl Esters of (-)-Carinol as Free-radical Scavengers and Xanthine Oxidase Enzyme Inhibitors: Synthesis and Biological Evaluation
Medicinal Chemistry Strategies for Salt Reduction in Foods
Recent Patents on Food, Nutrition & Agriculture Defensive and Offensive Cross-Reactive Antibodies Elicited by Pathogens: The Good, the Bad and the Ugly
Current Medicinal Chemistry Adiponectin: A Key Player in Obesity Related Disorders
Current Pharmaceutical Design Metabolic Syndrome and Non-Cardiac Vascular Diseases: An Update from Human Studies
Current Pharmaceutical Design Essential Fatty Acids - A Review
Current Pharmaceutical Biotechnology NOAC in Acute Coronary Syndrome and AF?
Cardiovascular & Hematological Disorders-Drug Targets Anesthetic Cardioprotection in Relation to Mitochondria: Basic Science
Current Pharmaceutical Design The Application of Fungal Beta-glucans for the Treatment of Colon Cancer
Anti-Cancer Agents in Medicinal Chemistry The Effect of Local Alcohol Delivery in Reducing Intimal Hyperplasia Induced by Vascular Injury and the Clinical Implications
Vascular Disease Prevention (Discontinued) Autophagy and Mitochondria in Obesity and Type 2 Diabetes
Current Diabetes Reviews Strategies for Enhancing Progenitor Cell Mobilization and Function in Diabetes
Current Vascular Pharmacology